QGEN
QGEN
NYSE · Life Sciences Tools & Services

Qiagen N.V.

$40.63
+0.85 (+2.14%)
Financial Highlights (FY 2026)
Revenue
1.88B
Net Income
381.35M
Gross Margin
62.2%
Profit Margin
20.3%
Rev Growth
-0.8%
D/E Ratio
0.39
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.2% 62.2% 30.4% 30.4%
Operating Margin 22.3% 20.1% 6.7% 6.5%
Profit Margin 20.3% 19.3% 4.1% 4.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.88B 1.89B 2.80B 2.83B
Gross Profit 1.17B 1.18B 851.01M 860.99M
Operating Income 418.13M 379.39M 188.75M 184.86M
Net Income 381.35M 346.01M 113.25M 136.27M
Gross Margin 62.2% 62.2% 30.4% 30.4%
Operating Margin 22.3% 20.1% 6.7% 6.5%
Profit Margin 20.3% 19.3% 4.1% 4.8%
Rev Growth -0.8% -0.8% +10.7% +5.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.40B 1.40B 2.25B 2.65B
Total Equity 3.59B 3.59B 7.69B 7.73B
D/E Ratio 0.39 0.39 0.29 0.34
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 419.34M 401.62M 241.59M 268.48M
Free Cash Flow 174.05M 184.00M